Active and acid-activable inactive renin during inhibition by indomethacin of prostaglandin synthesis in sodium-replete man. 1985

P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery

The effect of inhibition of prostaglandin synthesis by indomethacin on active renin and on acid-activable inactive renin was studied in nine healthy, sodium-replete men, both at rest and exercise. These volunteers were investigated after pretreatment with placebo or indomethacin, 150 mg daily for 3 days. Indomethacin induced a decrease in active (P = 0.004), total (P less than 0.001) and inactive (P = 0.02) renin at rest recumbent and at rest, sitting. Inhibition of prostaglandins with indomethacin reduced (P less than 0.001) active and total renin at each level of work load but not (P = 0.32) inactive renin. However the exercise-induced stimulation (P less than 0.05) of active and of total renin still occur during indomethacin. Indomethacin reduced (P less than 0.001) at rest, sitting and at maximal exercise the plasma concentrations of immunoreactive prostaglandins E2, prostaglandin F2 alpha and 13, 14-dihydro-15-keto-prostaglandin F alpha; the urinary excretion of immunoreactive prostaglandin E2 and F2 alpha were also reduced.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
December 1980, Prostaglandins and medicine,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
August 1987, Scandinavian journal of gastroenterology,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
November 1985, Gut,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
April 1980, The Journal of endocrinology,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
February 1983, The Journal of clinical endocrinology and metabolism,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
December 1977, The Journal of physiology,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
December 1978, Clinical science and molecular medicine. Supplement,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
August 1987, Nihon Jinzo Gakkai shi,
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
September 1992, Clinical science (London, England : 1979),
P Lijnen, and J Staessen, and R Fagard, and D Groeseneken, and J R M'Buyamba-Kabangu, and R Grauwels, and A Amery
February 1981, The American journal of physiology,
Copied contents to your clipboard!